The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy
REVIEW|Updated:2026-06-12
|
The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy
The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy
军事医学研究(英文)2026年
Affiliations:
Department of Urology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China
The Center of Psychosomatic Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China
Purdue Institute for Cancer Research, Purdue University, West Lafayette, IN 47907, USA
Division of Surgery & Interventional Science, University College London, London W1W 7TS, UK
Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China
Department of Gastroenterology and Hepatology and Shanghai Institute of Liver Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Department of Rehabilitation, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China
Rappaport Family Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, Haifa 31096, Israel
Department of Radiology, Division of Radiation Oncology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
Basic and Translational Cancer Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Enugu 340001, Nigeria
Faculty of Health and Life Sciences, University of Bristol, Bristol BS8 1TD, UK
Department of Urology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310009, China
Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou 310014, China
Author bio:
Da-Hong Zhang, urology@zju.edu.cn
Cheema Umber, u.cheema@ucl.ac.uk;
Qi Zhang, zhangqi1@hmc.edu.cn;
*De-Chao Feng, dechao.feng@ucl.ac.uk;
Funds:
the National Health Commission of the People’s Republic of China-Zhejiang Province Jointly Constructed Project, Zhejiang Province Medical and Health Science and Technology Plan(WKJ-ZJ-2517);Clinical-Basic Joint Research Project of Zhejiang Provincial People’s Hospital Affiliated with Hangzhou Medical College(C-2025-YXLH09);This program was supported by the Chinese Scholarship Council(202206240086)
Zhi-Peng Wang, Ai-Qing Li, Dilinaer Wusiman, 等. The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy[J/OL]. 军事医学研究(英文), 2026.
Wang ZP, Li AQ, Wusiman D, Wu RC, Zhu JM, Li XR, et al. The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy. Mil Med Res. 2026;13(1):100038.
Zhi-Peng Wang, Ai-Qing Li, Dilinaer Wusiman, 等. The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy[J/OL]. 军事医学研究(英文), 2026. DOI: 10.1016/j.mmr.2026.100038.
Wang ZP, Li AQ, Wusiman D, Wu RC, Zhu JM, Li XR, et al. The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy. Mil Med Res. 2026;13(1):100038. DOI: 10.1016/j.mmr.2026.100038.
The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy